Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Each vial is independently lab-tested
See the full starting-price breakdown before you enter payment info
Lillys reinforced dominance Lilly is already the market leader in obesity
In a double-blind study, semaglutide, a medication that acts like the GLP-1 hormone made by the body after eating, significantly benefited patients who were overweight or obese who had a history of heart disease but no diabetes
Reddy's Laboratories Cipla Lupin Zydus Lifesciences Goa HR Alkem Laboratories Ltd
US$ 23.69
US$ 27.15
US$ 21.23
US$ 24.51
US$ 28.90
US$ 24.08
US$ 27.44
US$ 28.55
US$ 21.38
